HK1258531A1 - 使用糞源細菌群落來治療微生態失衡的系統和方法 - Google Patents

使用糞源細菌群落來治療微生態失衡的系統和方法

Info

Publication number
HK1258531A1
HK1258531A1 HK19100886.6A HK19100886A HK1258531A1 HK 1258531 A1 HK1258531 A1 HK 1258531A1 HK 19100886 A HK19100886 A HK 19100886A HK 1258531 A1 HK1258531 A1 HK 1258531A1
Authority
HK
Hong Kong
Prior art keywords
dysbiosis
fecal
treating
systems
methods
Prior art date
Application number
HK19100886.6A
Other languages
English (en)
Inventor
艾瑪‧艾倫-費爾科
Original Assignee
努比約塔有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 努比約塔有限公司 filed Critical 努比約塔有限公司
Publication of HK1258531A1 publication Critical patent/HK1258531A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/742Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/10Enterobacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/33Assays involving biological materials from specific organisms or of a specific nature from bacteria from Clostridium (G)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK19100886.6A 2015-08-24 2019-01-17 使用糞源細菌群落來治療微生態失衡的系統和方法 HK1258531A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562209149P 2015-08-24 2015-08-24
PCT/US2016/048312 WO2017035188A1 (en) 2015-08-24 2016-08-24 Systems and methods for treating a dysbiosis using fecal-derived bacterial populations

Publications (1)

Publication Number Publication Date
HK1258531A1 true HK1258531A1 (zh) 2019-11-15

Family

ID=58100942

Family Applications (1)

Application Number Title Priority Date Filing Date
HK19100886.6A HK1258531A1 (zh) 2015-08-24 2019-01-17 使用糞源細菌群落來治療微生態失衡的系統和方法

Country Status (7)

Country Link
US (2) US20200390830A1 (zh)
EP (1) EP3341000A4 (zh)
JP (1) JP7088827B2 (zh)
CN (1) CN108289917A (zh)
CA (1) CA2995786A1 (zh)
HK (1) HK1258531A1 (zh)
WO (1) WO2017035188A1 (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108064132A (zh) 2014-10-31 2018-05-22 霍勒拜欧姆公司 与病症的微生物治疗和诊断有关的方法和组合物
US9999641B2 (en) 2016-06-14 2018-06-19 Vedanta Biosciences, Inc. Treatment of clostridium difficile infection
CA3073838A1 (en) 2017-08-30 2019-03-07 Pendulum Therapeutics, Inc. Methods and compositions for treatment of microbiome-associated disorders
JP2021502964A (ja) * 2017-11-14 2021-02-04 エヴェロ バイオサイエンシズ,インコーポレーテッド ブラウティア(Blautia)株を使用して疾患を処置するための組成物及び方法
FR3083545A1 (fr) 2018-07-04 2020-01-10 Institut National De La Recherche Agronomique Utilisation d'une souche de roseburia intestinalis pour la prevention et le traitement de l'inflammation de l'intestin
WO2020135689A1 (en) * 2018-12-27 2020-07-02 The Chinese University Of Hong Kong Therapeutic and prophylactic use of microorganisms
CN110051698A (zh) * 2019-03-18 2019-07-26 天津大学 基于微囊化处理的肠道原生菌基因改造的方法
CN110839693B (zh) * 2019-11-07 2023-03-28 慕恩(广州)生物科技有限公司 吉氏副拟杆菌在预防或治疗肥胖或其相关疾病中的应用
EP3858363A1 (en) 2020-01-28 2021-08-04 Institut national de recherche pour l'agriculture, l'alimentation et l'environnement Composition for treating intestinal or pulmonary diseases
KR102269962B1 (ko) * 2020-12-11 2021-06-28 주식회사 바이오뱅크힐링 유박테리움 리모숨 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
CN113604378A (zh) * 2021-07-05 2021-11-05 华南理工大学 一种制备罗汉果甜苷代谢产物的复合菌剂及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0903016D0 (en) * 2009-02-23 2009-04-08 Univ Gent Method for alleviating intestinal problems and novel bacterial strains therefor
WO2011009099A1 (en) * 2009-07-16 2011-01-20 The Regents Of The University Of California Metabolic biomarkers of crohn's disease
CN102711819A (zh) * 2009-09-23 2012-10-03 托马斯·朱利叶斯·波洛迪 肠道感染疗法
CN102711778B (zh) * 2009-11-02 2015-06-24 热尔韦法国达能公司 利用动物双歧杆菌细菌或含有这种细菌的发酵乳制品减轻胃肠炎症的方法
US20140363397A1 (en) * 2011-09-14 2014-12-11 Queen's University At Kingston Method for treatment of disorders of the gastrointestinal system
EP3584308A3 (en) * 2013-02-04 2020-03-04 Seres Therapeutics, Inc. Compositions and methods
CA2941917C (en) * 2013-03-14 2021-05-18 University Of Ottawa Methods for the diagnosis and treatment of inflammatory bowel disease

Also Published As

Publication number Publication date
JP7088827B2 (ja) 2022-06-21
EP3341000A4 (en) 2019-02-20
WO2017035188A1 (en) 2017-03-02
CN108289917A (zh) 2018-07-17
US20200390830A1 (en) 2020-12-17
JP2018526374A (ja) 2018-09-13
EP3341000A1 (en) 2018-07-04
US20210393707A1 (en) 2021-12-23
CA2995786A1 (en) 2017-03-02

Similar Documents

Publication Publication Date Title
HK1258531A1 (zh) 使用糞源細菌群落來治療微生態失衡的系統和方法
HK1246941A1 (zh) 訂單處理方法及系統
HK1257811A1 (zh) 方法、系統及裝置
EP3233313C0 (en) SORTING SYSTEM WITH SEVERAL SORTING DEVICES AND CORRESPONDING SORTING METHOD
PL3266531T3 (pl) Układy pras i wykorzystujące je sposoby
HK1244388A1 (zh) 方法、裝置和系統
SG10202002519UA (en) Maintenance systems and methods for medical devices
SG11201912231VA (en) Systems and methods for blockchain-dependent operation sets
GB2543202B (en) Well ranging apparatus, methods, and systems
GB2549200B (en) Well ranging apparatus, methods and systems
HK1212015A1 (zh) 儲物柜及其控制方法和控制系統
HK1221779A1 (zh) 使用典型零件及連接零件的程序控制系統
PT3210417T (pt) Método e aparelho para adquirir informações de sistema
GB2548965B (en) Gripping apparatus and associated systems
GB201417624D0 (en) Apparatus, system and method
GB201520385D0 (en) Off-line transaction method and system
GB2547173B (en) Blade-mounted sensor apparatus, systems, and methods
GB201501809D0 (en) Apparatus, system and method
SG11201704784WA (en) Modular valve apparatus and system
GB201703314D0 (en) Solids control methods, apparatus, and systems
GB201415688D0 (en) Method and Systems
GB201607402D0 (en) Systems, devices, and methods for distributed processing
GB2540193B (en) Controller, system and method
GB201414572D0 (en) Apparatus, System and Method
IL248444B (en) System and method for desalination of sea water